期刊文献+

乳腺癌MCF-7细胞CD44^+CD24^-表达与放化疗抵抗及转移潜能相关性研究 被引量:2

Chemoradioresistance and metastatic potential relevance in CD44^+CD24^- expressed MCF-7 cells
原文传递
导出
摘要 目的明确乳腺癌MCF-7细胞CD44+CD24-表达是否具有放化疗抵抗性,并研究其转移潜能相关性。方法无菌条件下通过FACS分选出CD44+CD24-MCF-7和non CD44+CD24-MCF-7两组细胞,进行同种条件下传代培养,采用5-氟尿嘧啶(5-FU)及医用X射线对两组细胞进行干预,对比检测两组细胞经干预后的生物学特性差异、体外侵袭能力及侵袭关联基因表达差异。MTT实验检测两组细胞经不同药物浓度的5-FU处理后细胞增殖率差异;流式细胞术检测经同种药物浓度的5-FU处理后两组细胞的周期及凋亡;彗星实验检测两组细胞经医用X射线照射后细胞DNA的损伤;蛋白质印迹法检测两组细胞侵袭相关基因PRDM14表达;基质胶侵袭性实验用于对比两组细胞体外侵袭能力差异。结果CD44+CD24-MCF-7细胞增殖抑制率为(93.86±2.95)%,与non CD44+CD24-MCF-7细胞(334.21±4.20)%比较明显下降,其IC50值约为后者4倍,u=0.38,P<0.01;细胞凋亡率CD44+CD24-MCF-7细胞为(8.77±0.66)%,较non CD44+CD24-MCF-7细胞(28.64±1.25)%显著降低,u=0.42,P=0.014;静止期(G0/G1期)CD44+CD24-MCF-7细胞为(76.19±1.623)%,较non CD44+CD24-MCF-7细胞(49.74±3.214)%明显增多,u=0.35,P=0.025;DNA损伤(4Gy Olive尾距值)CD44+CD24-MCF-7为13.130 0±0.542 8,较non CD44+CD24-MCF-7细胞33.250 0±0.932 7轻,P<0.000 1;体外侵袭能力CD44+CD24-MCF-7为75.28±6.932,较non CD44+CD24-MCF-7细胞24.23±3.408更强,P=0.007 6;PRDM14蛋白表达CD44+CD24-MCF-7为0.95±0.62,较non CD44+CD24-MCF-7细胞0.33±0.44上调,P<0.01。结论 CD44+CD24-MCF-7细胞相比non CD44+CD24-MCF-7细胞具有明显不同的细胞生物学特性,表明CD44+CD24-MCF-7表达细胞不仅具有明显的放化疗抵抗性,而且具有一定的转移潜能,在乳腺癌的化疗耐药或晚期转移中可能扮演一定的作用。 OBJECTIVE To clarify whether MCF-7 ceils with CD44+ CD24- expression were resistant to chemo-ra- diotherapy and relevant to metastatic potential. METHODS Two groups of cells (CD44+ CD24- cells and non CD44+ CD24- cells) were sorted from the breast cancer cells lines MCF-7 by FACS under sterile conditions. Then this two groups of cells were cultured in the same condition. Biological characteristics of the cells were detected after the treatment of chemotherapy drugs and medical X-ray irradiations Its invasiveness capacity in vitro and the expression of invasiveness- related gene were further tested in the two group cells. MTT assay was introduced to detect the cell proliferation ratio af- ter different doses of 5-FU treatment; The cell cycle and cell apoptosis were detected by FCM; DNA breaks were detected by Comet assay after the irradiation of X-ray; Western blotting was used to detect the expression of invasion related genes PRDM14; Matrigel invasion experiments (Transwell assay) were used to compare the differences of invasion ability in the two group cells in vitro. RESULTS Compare to non CD44+ CD24 MCF-7 cells, apoptosis rate (8.77 ± 0. 66)% vs (28.64± 1.25)% (p = 0. 014) was significantly reduced and proliferation rate, IC50: (334. 21 ±4. 20) % vs ( 93. 86 ±2.95) % (P〈0.01)was increased in CD44+ CD24- MCF-7 cells; Quiescent cells increased significantly [Go/G1 :(76.19± 1. 623)% vs (49.74±3. 214)% , (P= 0. 025)]; DNA breaks of CD44+ CD24- MCF-7 cells were significantly decreased (4 Gy OTM value: 13. 130 0±0. 542 8 vs 33. 250 0i0. 932 7, P〈0. 000 1) % CD44+ CD24- MCF-7 had a stronger inva- sive capability in vitro (75.28±6. 932 vs 24.23±3. 408,P=0. 007 6) and highly expressed PRDM14 protein (0.95± 0.62 vs O. 33vs0.44,P〈0.01). CONCLUSIONS CD44+ CD24- MCF-7 cells have quite different biological characteris- tics compared to CD44+ CD24- MCF-7 cells, which reveals that MCF-7 cells not only have a signi{icant resistance
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第13期1004-1008,1013,共6页 Chinese Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤 MCF-7 PRDM14 放化疗抵抗性 癌转移 breast neoplasms MCF-7 PRDM14 ehemoradio-resistance cancer invasion
  • 相关文献

参考文献2

二级参考文献9

  • 1Al-Hajj M, Wicha MS,Benito-Hernandez A,et al. Prospective i-dentification of tumorigenic breast cancer cells [J]. Proc NatlAcad Sci USA,2003,100(7) :3983-3988. 被引量:1
  • 2Yu F,Yao H,Zhu P,et al. let-7 regulates self renewal and tumorige-nicity of breast cancer cells[J]. Cell?2007,131(6) :1109-1123. 被引量:1
  • 3Livak KJ, Schmittgen TD. Analysis of relative gene expressiondata using real-time quantitative PCR and the 2 (-Delta DeltaC(T)) Method[J]. Methods,2001,25(4) :402-408. 被引量:1
  • 4Iliopoulos D, Hirsch HA, Wang G, et al. Inducible formation ofbreast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion[J]. Proc Natl Acad Sci U SA,2011,108(4):1397-1402. 被引量:1
  • 5Tiirk D,Szakacs G. Relevance of multidrug resistance in the ageof targeted therapy [J]. Curr Opin Drug Discov Devel, 2009,12(2): 246-252. 被引量:1
  • 6Navarro G?Sawant RR,Biswas S,et al. P-glycoprotein silencingwith siRNA delivered by DOPE-modified PEI overcomes doxoru-bicin resistance in breast cancer cells[J]. Nanomedicine, 2012, 7(1):65-78. 被引量:1
  • 7Zhang X,Wu X,Li J,et al. MDR1 (multidrug resistance 1) canregulate GCS (glucosylceramide synthase) in breast cancer cells[J]. J Surg Oncol,2011,104(5) =466-471. 被引量:1
  • 8刘新兰,陈萍,崔洁,张桂香.乳腺癌组织多药耐药相关蛋白表达及其与化疗疗效的相关性研究[J].中华肿瘤防治杂志,2011,18(17):1354-1357. 被引量:4
  • 9张海嫦,张飞,武冰,韩敬华,杨毅,冀为,周岩,牛瑞芳.Anxa2和P-gp蛋白相互作用对多药耐药乳腺癌细胞迁移与侵袭影响的研究[J].中华肿瘤防治杂志,2012,19(3):166-171. 被引量:6

共引文献18

同被引文献26

  • 1A1-Hajj M, Wicha MS,Bcnito-Hernandez A,et al.Prospective identification of tumorigenic Bre-ast cancer cells[J]. Proc Natl Acad Sci USA,21103,100(7):3988-3983. 被引量:1
  • 2Shipitsin M,Campbell LL,Argani P,et al.Molecular definition of breast tumor heterogeneity[J].Cancer Ce11,2007,11(3):259-273. 被引量:1
  • 3Jino Park, Michaela Schlederer, Martin Schreiber,et al.AFlq is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis[J].Oncotarget, 2015,6(24):20697-20710. 被引量:1
  • 4LingMei Li,LiSha Q, ZhiJie Liang, et al.Transforming growth factor- 13 1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells[J].INTERNATIONAL JOURNAL OF MOLECULAR. MEDICINE,2015,36:113-122. 被引量:1
  • 5Chen and Bourguignon.Hyaluronan-CD44 interaction promotes c-Jun signaling and miR-NA21 expression leading to Bcl- 2 expression and chemoresistance in breast cancer Cells[J].Molecular Cancer ,2014, 52:1-13. 被引量:1
  • 6Shannon M.Smith, Yi Lisa Lyu, Li Cai.NF-kB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression[J].PLOS ONE,2015,9(9), 1-10. 被引量:1
  • 7Yunhee Cho, Hyun-Woo Lee, Hyeok-Gu Kang, et al.Cleaved CD44 intracellular domain sup-ports activation of sternness factors and promotes tumorigenesis of breast cancer[J].OncoTarget, 2015, 6(11):8709-8721. 被引量:1
  • 8Cuixia Yang, Yiqing He, Huizhen Zhang,et al.Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo[J].Oncotarget, 2014, 6(17):15283-15296. 被引量:1
  • 9Phuc Van Pham, Ngoc Bich Vu, Thuy Thanh Duong, et al.Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment[J].OncoTargets and Terapy,2012,5:7784. 被引量:1
  • 10CufiSilvia,Bruna Corominas-Faja,Alejandro Vazquez- Martin,et al.Metformin-induced preferential killing of breast cancer initiating CD44+CD24-~'W cells is suffcient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts[J].Oncotarget, 2012,3( 4):395-398. 被引量:1

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部